English

CLEARPOINT NEURO, INC.

EDGAR

CLPT Quarterly report (10-Q) · filed 2026-10-28

Annual consolidated revenue for 2025: about USD 36.97M, using the latest reported figures. The previous period, 2024, was about USD 31.39M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

12.1 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 12075000 USD Source

Operating margin

-52.44%

2026 Q3 · %

Exact inputs and evidence

Operating Income: -6332000 USD Source
Revenue: 12075000 USD Source

Operating cash flow

-20.1 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -20100000 USD Source

Free cash flow

-20.2 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -20100000 USD Source
Capital Expenditure: 996000 USD Source
Capital Expenditure: 859000 USD Source

Cash and cash equivalents: 46.2 million USD 2026-09-30 Source
Exact value

46200000 USD
Long-term debt including current maturities: 50.8 million USD 2026-09-30 Source
Exact value

50840000 USD
Shares outstanding: 32.1 million shares 2026-09-30 Source
Exact value

32051494 shares

Reported share-count change

12.75% · 3.62 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

28428176 shares · 2025-09-30· Source
32051494 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

45.5 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Revenue: 36971000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 26561000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 12128000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 10880000 USD · 2026-04-01 – 2026-06-30 Source
Revenue: 12075000 USD · 2026-07-01 – 2026-09-30 Source

Net income

-36.1 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Net income: -25540000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -17754000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -9552000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -11337000 USD · 2026-04-01 – 2026-06-30 Source
Net income: -7460000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-47.2 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -23900000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -11845000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -8000000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -15000000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -8000000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -20100000 USD · 2026-07-01 – 2026-09-30 Source

Capital expenditure

1.05 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Capital expenditure: 522000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 473000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 645000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 859000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 645000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 996000 USD · 2026-01-01 – 2026-09-30 Source
Capital expenditure: 859000 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

-48.2 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -23900000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -11845000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -8000000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -15000000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -8000000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -20100000 USD · 2026-07-01 – 2026-09-30 Source
Capital expenditure: 522000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 473000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 645000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 859000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 645000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 996000 USD · 2026-01-01 – 2026-09-30 Source
Capital expenditure: 859000 USD · 2026-01-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-28.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 10 of 11 periods available· newest 2025-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.8%

Prior period

USD 31.39 million

2024-01-01 – 2024-12-31
Current period

USD 36.97 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

36971000 − 31390000 = 5581000 USD

31390000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
36971000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Year-over-year change in Revenue: 5581000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 36971000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2541704 Filing: 000119312526111231 Input fundies:Revenue: 31390000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2543519 Filing: 000119312526111231
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.63 million

Prior period

−USD 18.91 million

2024-01-01 – 2024-12-31
Current period

−USD 25.54 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-25540000 − -18914000 = -6626000 USD

-18914000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-25540000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Year-over-year change in Net income: -6626000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -25540000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2118292 Filing: 000119312526111231 Input fundies:NetIncome: -18914000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2120023 Filing: 000119312526111231
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 14.95 million

Prior period

−USD 8.95 million

2024-01-01 – 2024-12-31
Current period

−USD 23.9 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-23900000 − -8950000 = -14950000 USD

-8950000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-23900000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Year-over-year change in Operating cash flow: -14950000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -23900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526436412/clpt-20260930.htm#1147028 Filing: 000119312526436412 Input fundies:OperatingCashFlow: -8950000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2183868 Filing: 000119312526111231
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+89.8%

Prior period

USD 275,000

2024-01-01 – 2024-12-31
Current period

USD 522,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

522000 − 275000 = 247000 USD

275000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
522000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Year-over-year change in Capital expenditure: 247000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 522000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2192536 Filing: 000119312526111231 Input fundies:CapitalExpenditure: 275000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2194413 Filing: 000119312526111231
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 36.97 million 100% of revenue
Cost of revenue USD 14.28 million 39% of revenue
Operating expenses USD 30.4 million 82% of revenue
Other operating costs Derived USD 16.46 million 45% of revenue
Operating income −USD 24.16 million −65% of revenue
Tax, interest and other Derived USD 1.38 million 3.7% of revenue
Net income −USD 25.54 million −69% of revenue

Cash

Operating cash flow −USD 23.9 million −65% of revenue
Capital expenditure USD 522,000 1.4% of revenue
Free cash flow Derived −USD 24.42 million −66% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 230% of revenue.
2017 Operating loss: operating costs were 186% of revenue.
2018 Operating loss: operating costs were 171% of revenue.
2019 Operating loss: operating costs were 141% of revenue.
2020 Operating loss: operating costs were 148% of revenue.
2021 Operating loss: operating costs were 182% of revenue.
2022 Operating loss: operating costs were 179% of revenue.
2023 Operating loss: operating costs were 194% of revenue.
2024 Operating loss: operating costs were 163% of revenue.
2025 Operating loss: operating costs were 165% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	5749454	13238192 Derived	-7488738	581157 Derived	-8069895	-5921045 Derived	Source 2016-01-01 – 2016-12-31: 5749454 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -7488738 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -8069895 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -5820043 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 101002 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	7379525	13715362 Derived	-6335837	831516 Derived	-7167353	-6019263 Derived	Source 2017-01-01 – 2017-12-31: 7379525 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -6335837 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -7167353 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5992511 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 26752 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	7353266	12601034 Derived	-5247768	915701 Derived	-6163469	-4694082 Derived	Source 2018-01-01 – 2018-12-31: 7353266 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -5247768 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -6163469 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -4630592 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 63490 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	11217000	15811000 Derived	-4594000	946000 Derived	-5540000	-2860000 Derived	Source 2019-01-01 – 2019-12-31: 11217000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -4594000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -5540000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -2850000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 10000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	12829000	19049000 Derived	-6220000	562000 Derived	-6782000	-7848000 Derived	Source 2020-01-01 – 2020-12-31: 12829000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -6220000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -6782000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -7807000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 41000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	16299000	29673000 Derived	-13374000	1036000 Derived	-14410000	-12865000 Derived	Source 2021-01-01 – 2021-12-31: 16299000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -13374000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -14410000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -12697000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 168000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	20551000	36883000 Derived	-16332000	103000 Derived	-16435000	-16420000 Derived	Source 2022-01-01 – 2022-12-31: 20551000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -16332000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -16435000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -16167000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 253000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	23955000	46401000 Derived	-22446000	-357000 Derived	-22089000	-14437000 Derived	Source 2023-01-01 – 2023-12-31: 23955000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -22446000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -22089000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -13720000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 717000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	31390000	51124000 Derived	-19734000	-820000 Derived	-18914000	-9225000 Derived	Source 2024-01-01 – 2024-12-31: 31390000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -19734000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -18914000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -8950000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 275000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	36971000	61135000 Derived	-24164000	1376000 Derived	-25540000	-24422000 Derived	Source 2025-01-01 – 2025-12-31: 36971000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -24164000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -25540000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -23900000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 522000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 37M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	5749454	Revenue: 5749454 Open source
20172017-12-31	Revenue	7379525	Revenue: 7379525 Open source
20182018-12-31	Revenue	7353266	Revenue: 7353266 Open source
20192019-12-31	Revenue	11217000	Revenue: 11217000 Open source
20202020-12-31	Revenue	12829000	Revenue: 12829000 Open source
20212021-12-31	Revenue	16299000	Revenue: 16299000 Open source
20222022-12-31	Revenue	20551000	Revenue: 20551000 Open source
20232023-12-31	Revenue	23955000	Revenue: 23955000 Open source
20242024-12-31	Revenue	31390000	Revenue: 31390000 Open source
20252025-12-31	Revenue	36971000	Revenue: 36971000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	25.1%	Revenue: 5749454 Open source Revenue: 4594192 Open source
20172017-12-31	Year over year	28.4%	Revenue: 7379525 Open source Revenue: 5749454 Open source
20182018-12-31	Year over year	-0.4%	Revenue: 7353266 Open source Revenue: 7379525 Open source
20192019-12-31	Year over year	52.5%	Revenue: 11217000 Open source Revenue: 7353266 Open source
20202020-12-31	Year over year	14.4%	Revenue: 12829000 Open source Revenue: 11217000 Open source
20212021-12-31	Year over year	27%	Revenue: 16299000 Open source Revenue: 12829000 Open source
20222022-12-31	Year over year	26.1%	Revenue: 20551000 Open source Revenue: 16299000 Open source
20232023-12-31	Year over year	16.6%	Revenue: 23955000 Open source Revenue: 20551000 Open source
20242024-12-31	Year over year	31%	Revenue: 31390000 Open source Revenue: 23955000 Open source
20252025-12-31	Year over year	17.8%	Revenue: 36971000 Open source Revenue: 31390000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -65.4% 2025

Net margin -69.1% 2025

Free cash flow margin -66.1% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-130.3%	Operating Income: -7488738 Open source Revenue: 5749454 Open source
20172017-12-31	Operating margin	-85.9%	Operating Income: -6335837 Open source Revenue: 7379525 Open source
20182018-12-31	Operating margin	-71.4%	Operating Income: -5247768 Open source Revenue: 7353266 Open source
20192019-12-31	Operating margin	-41%	Operating Income: -4594000 Open source Revenue: 11217000 Open source
20202020-12-31	Operating margin	-48.5%	Operating Income: -6220000 Open source Revenue: 12829000 Open source
20212021-12-31	Operating margin	-82.1%	Operating Income: -13374000 Open source Revenue: 16299000 Open source
20222022-12-31	Operating margin	-79.5%	Operating Income: -16332000 Open source Revenue: 20551000 Open source
20232023-12-31	Operating margin	-93.7%	Operating Income: -22446000 Open source Revenue: 23955000 Open source
20242024-12-31	Operating margin	-62.9%	Operating Income: -19734000 Open source Revenue: 31390000 Open source
20252025-12-31	Operating margin	-65.4%	Operating Income: -24164000 Open source Revenue: 36971000 Open source
20162016-12-31	Net margin	-140.4%	Net Income: -8069895 Open source Revenue: 5749454 Open source
20172017-12-31	Net margin	-97.1%	Net Income: -7167353 Open source Revenue: 7379525 Open source
20182018-12-31	Net margin	-83.8%	Net Income: -6163469 Open source Revenue: 7353266 Open source
20192019-12-31	Net margin	-49.4%	Net Income: -5540000 Open source Revenue: 11217000 Open source
20202020-12-31	Net margin	-52.9%	Net Income: -6782000 Open source Revenue: 12829000 Open source
20212021-12-31	Net margin	-88.4%	Net Income: -14410000 Open source Revenue: 16299000 Open source
20222022-12-31	Net margin	-80%	Net Income: -16435000 Open source Revenue: 20551000 Open source
20232023-12-31	Net margin	-92.2%	Net Income: -22089000 Open source Revenue: 23955000 Open source
20242024-12-31	Net margin	-60.3%	Net Income: -18914000 Open source Revenue: 31390000 Open source
20252025-12-31	Net margin	-69.1%	Net Income: -25540000 Open source Revenue: 36971000 Open source
20162016-12-31	Free cash flow margin	-103%	Revenue: 5749454 Open source Operating Cash Flow: -5820043 Open source Capital Expenditure: 101002 Open source
20172017-12-31	Free cash flow margin	-81.6%	Revenue: 7379525 Open source Operating Cash Flow: -5992511 Open source Capital Expenditure: 26752 Open source
20182018-12-31	Free cash flow margin	-63.8%	Revenue: 7353266 Open source Operating Cash Flow: -4630592 Open source Capital Expenditure: 63490 Open source
20192019-12-31	Free cash flow margin	-25.5%	Revenue: 11217000 Open source Operating Cash Flow: -2850000 Open source Capital Expenditure: 10000 Open source
20202020-12-31	Free cash flow margin	-61.2%	Revenue: 12829000 Open source Operating Cash Flow: -7807000 Open source Capital Expenditure: 41000 Open source
20212021-12-31	Free cash flow margin	-78.9%	Revenue: 16299000 Open source Operating Cash Flow: -12697000 Open source Capital Expenditure: 168000 Open source
20222022-12-31	Free cash flow margin	-79.9%	Revenue: 20551000 Open source Operating Cash Flow: -16167000 Open source Capital Expenditure: 253000 Open source
20232023-12-31	Free cash flow margin	-60.3%	Revenue: 23955000 Open source Operating Cash Flow: -13720000 Open source Capital Expenditure: 717000 Open source
20242024-12-31	Free cash flow margin	-29.4%	Revenue: 31390000 Open source Operating Cash Flow: -8950000 Open source Capital Expenditure: 275000 Open source
20252025-12-31	Free cash flow margin	-66.1%	Revenue: 36971000 Open source Operating Cash Flow: -23900000 Open source Capital Expenditure: 522000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -23.9M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-5820043	Operating Cash Flow: -5820043 Open source
20172017-12-31	Operating cash flow	-5992511	Operating Cash Flow: -5992511 Open source
20182018-12-31	Operating cash flow	-4630592	Operating Cash Flow: -4630592 Open source
20192019-12-31	Operating cash flow	-2850000	Operating Cash Flow: -2850000 Open source
20202020-12-31	Operating cash flow	-7807000	Operating Cash Flow: -7807000 Open source
20212021-12-31	Operating cash flow	-12697000	Operating Cash Flow: -12697000 Open source
20222022-12-31	Operating cash flow	-16167000	Operating Cash Flow: -16167000 Open source
20232023-12-31	Operating cash flow	-13720000	Operating Cash Flow: -13720000 Open source
20242024-12-31	Operating cash flow	-8950000	Operating Cash Flow: -8950000 Open source
20252025-12-31	Operating cash flow	-23900000	Operating Cash Flow: -23900000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -24.4M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-5921045	Operating Cash Flow: -5820043 Open source Capital Expenditure: 101002 Open source
20172017-12-31	Free cash flow	-6019263	Operating Cash Flow: -5992511 Open source Capital Expenditure: 26752 Open source
20182018-12-31	Free cash flow	-4694082	Operating Cash Flow: -4630592 Open source Capital Expenditure: 63490 Open source
20192019-12-31	Free cash flow	-2860000	Operating Cash Flow: -2850000 Open source Capital Expenditure: 10000 Open source
20202020-12-31	Free cash flow	-7848000	Operating Cash Flow: -7807000 Open source Capital Expenditure: 41000 Open source
20212021-12-31	Free cash flow	-12865000	Operating Cash Flow: -12697000 Open source Capital Expenditure: 168000 Open source
20222022-12-31	Free cash flow	-16420000	Operating Cash Flow: -16167000 Open source Capital Expenditure: 253000 Open source
20232023-12-31	Free cash flow	-14437000	Operating Cash Flow: -13720000 Open source Capital Expenditure: 717000 Open source
20242024-12-31	Free cash flow	-9225000	Operating Cash Flow: -8950000 Open source Capital Expenditure: 275000 Open source
20252025-12-31	Free cash flow	-24422000	Operating Cash Flow: -23900000 Open source Capital Expenditure: 522000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

71.3% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	110.2%	Total Liabilities: 8156954 Open source Total Assets: 7400885 Open source
20172017-12-31	Liabilities / assets	58.1%	Total Liabilities: 8068625 Open source Total Assets: 13897365 Open source
20182018-12-31	Liabilities / assets	80.8%	Total Liabilities: 6345831 Open source Total Assets: 7856833 Open source
20192019-12-31	Liabilities / assets	61.5%	Total Liabilities: 7341000 Open source Total Assets: 11927000 Open source
20202020-12-31	Liabilities / assets	91.9%	Total Liabilities: 27141000 Open source Total Assets: 29518000 Open source
20212021-12-31	Liabilities / assets	25.6%	Total Liabilities: 16794000 Open source Total Assets: 65581000 Open source
20222022-12-31	Liabilities / assets	33.5%	Total Liabilities: 18603000 Open source Total Assets: 55490000 Open source
20232023-12-31	Liabilities / assets	50.4%	Total Liabilities: 21488000 Open source Total Assets: 42661000 Open source
20242024-12-31	Liabilities / assets	35.2%	Total Liabilities: 13800000 Open source Total Assets: 39189000 Open source
20252025-12-31	Liabilities / assets	71.3%	Total Liabilities: 69727000 Open source Total Assets: 97747000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.91× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	2.02×	Current Assets: 6085095 Open source Current Liabilities: 3017700 Open source
20172017-12-31	Current assets / current liabilities	2.9×	Current Assets: 12746157 Open source Current Liabilities: 4398013 Open source
20182018-12-31	Current assets / current liabilities	3.56×	Current Assets: 6654689 Open source Current Liabilities: 1867495 Open source
20192019-12-31	Current assets / current liabilities	2.71×	Current Assets: 10384000 Open source Current Liabilities: 3833000 Open source
20202020-12-31	Current assets / current liabilities	7.96×	Current Assets: 25462000 Open source Current Liabilities: 3200000 Open source
20212021-12-31	Current assets / current liabilities	13.02×	Current Assets: 61892000 Open source Current Liabilities: 4753000 Open source
20222022-12-31	Current assets / current liabilities	7.54×	Current Assets: 51180000 Open source Current Liabilities: 6788000 Open source
20232023-12-31	Current assets / current liabilities	4.87×	Current Assets: 36172000 Open source Current Liabilities: 7430000 Open source
20242024-12-31	Current assets / current liabilities	3.22×	Current Assets: 33363000 Open source Current Liabilities: 10353000 Open source
20252025-12-31	Current assets / current liabilities	5.91×	Current Assets: 63600000 Open source Current Liabilities: 10765000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 8.07 million Exact value Exact value: -8069895 USD 2016-01-01 – 2016-12-31: -8069895 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2016-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -8069895 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8069895 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442418000090/mric-20171231.xml#127764 Filing: 000153442418000090 The citation records this snapshot. The page link may show a newer release later.	−USD 5.82 million Exact value Exact value: -5820043 USD 2016-01-01 – 2016-12-31: -5820043 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2016-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -5820043 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5820043 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442418000090/mric-20171231.xml#144317 Filing: 000153442418000090 The citation records this snapshot. The page link may show a newer release later.	USD 101,002 Exact value Exact value: 101002 USD 2016-01-01 – 2016-12-31: 101002 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2016-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 101002 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 101002 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442418000090/mric-20171231.xml#143949 Filing: 000153442418000090 The citation records this snapshot. The page link may show a newer release later.	−USD 5.92 million Calculation and evidence -5820043 − 101002 USD Exact free cash flow: -5921045 USD 2016-01-01 – 2016-12-31: -5820043 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 101002 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2016-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -5921045 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5820043 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442418000090/mric-20171231.xml#144317 Filing: 000153442418000090 Input fundies:CapitalExpenditure: 101002 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442418000090/mric-20171231.xml#143949 Filing: 000153442418000090 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 7.17 million Exact value Exact value: -7167353 USD 2017-01-01 – 2017-12-31: -7167353 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2017-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -7167353 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7167353 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442419000092/mric-20181231.xml#102564 Filing: 000153442419000092 The citation records this snapshot. The page link may show a newer release later.	−USD 5.99 million Exact value Exact value: -5992511 USD 2017-01-01 – 2017-12-31: -5992511 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2017-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -5992511 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5992511 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442419000092/mric-20181231.xml#105296 Filing: 000153442419000092 The citation records this snapshot. The page link may show a newer release later.	USD 26,752 Exact value Exact value: 26752 USD 2017-01-01 – 2017-12-31: 26752 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2017-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 26752 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26752 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442419000092/mric-20181231.xml#107859 Filing: 000153442419000092 The citation records this snapshot. The page link may show a newer release later.	−USD 6.02 million Calculation and evidence -5992511 − 26752 USD Exact free cash flow: -6019263 USD 2017-01-01 – 2017-12-31: -5992511 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 26752 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2017-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -6019263 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5992511 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442419000092/mric-20181231.xml#105296 Filing: 000153442419000092 Input fundies:CapitalExpenditure: 26752 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000153442419000092/mric-20181231.xml#107859 Filing: 000153442419000092 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 6.16 million Exact value Exact value: -6163469 USD 2018-01-01 – 2018-12-31: -6163469 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2018-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -6163469 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6163469 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152020000159/clpt-20191231.xml#80679 Filing: 000117152020000159 The citation records this snapshot. The page link may show a newer release later.	−USD 4.63 million Exact value Exact value: -4630592 USD 2018-01-01 – 2018-12-31: -4630592 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2018-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -4630592 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4630592 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152020000159/clpt-20191231.xml#527050 Filing: 000117152020000159 The citation records this snapshot. The page link may show a newer release later.	USD 63,490 Exact value Exact value: 63490 USD 2018-01-01 – 2018-12-31: 63490 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2018-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 63490 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63490 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152020000159/clpt-20191231.xml#526686 Filing: 000117152020000159 The citation records this snapshot. The page link may show a newer release later.	−USD 4.69 million Calculation and evidence -4630592 − 63490 USD Exact free cash flow: -4694082 USD 2018-01-01 – 2018-12-31: -4630592 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 63490 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2018-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -4694082 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4630592 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152020000159/clpt-20191231.xml#527050 Filing: 000117152020000159 Input fundies:CapitalExpenditure: 63490 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152020000159/clpt-20191231.xml#526686 Filing: 000117152020000159 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 5.54 million Exact value Exact value: -5540000 USD 2019-01-01 – 2019-12-31: -5540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2019-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -5540000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5540000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152021000138/clpt-20201231.xml#92821 Filing: 000117152021000138 The citation records this snapshot. The page link may show a newer release later.	−USD 2.85 million Exact value Exact value: -2850000 USD 2019-01-01 – 2019-12-31: -2850000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2019-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -2850000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152021000138/clpt-20201231.xml#105005 Filing: 000117152021000138 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 2019-01-01 – 2019-12-31: 10000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2019-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 10000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152021000138/clpt-20201231.xml#105374 Filing: 000117152021000138 The citation records this snapshot. The page link may show a newer release later.	−USD 2.86 million Calculation and evidence -2850000 − 10000 USD Exact free cash flow: -2860000 USD 2019-01-01 – 2019-12-31: -2850000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 10000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2019-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -2860000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152021000138/clpt-20201231.xml#105005 Filing: 000117152021000138 Input fundies:CapitalExpenditure: 10000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000117152021000138/clpt-20201231.xml#105374 Filing: 000117152021000138 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 6.78 million Exact value Exact value: -6782000 USD 2020-01-01 – 2020-12-31: -6782000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2020-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -6782000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6782000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000003/clpt-20211231.htm#1152913 Filing: 000128555022000003 The citation records this snapshot. The page link may show a newer release later.	−USD 7.81 million Exact value Exact value: -7807000 USD 2020-01-01 – 2020-12-31: -7807000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2020-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -7807000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7807000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000003/clpt-20211231.htm#1188089 Filing: 000128555022000003 The citation records this snapshot. The page link may show a newer release later.	USD 41,000 Exact value Exact value: 41000 USD 2020-01-01 – 2020-12-31: 41000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2020-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 41000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 41000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000003/clpt-20211231.htm#1190762 Filing: 000128555022000003 The citation records this snapshot. The page link may show a newer release later.	−USD 7.85 million Calculation and evidence -7807000 − 41000 USD Exact free cash flow: -7848000 USD 2020-01-01 – 2020-12-31: -7807000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 41000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2020-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -7848000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7807000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000003/clpt-20211231.htm#1188089 Filing: 000128555022000003 Input fundies:CapitalExpenditure: 41000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555022000003/clpt-20211231.htm#1190762 Filing: 000128555022000003 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 14.41 million Exact value Exact value: -14410000 USD 2021-01-01 – 2021-12-31: -14410000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2021-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -14410000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14410000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000020/clpt-20221231.htm#1124916 Filing: 000128555023000020 The citation records this snapshot. The page link may show a newer release later.	−USD 12.7 million Exact value Exact value: -12697000 USD 2021-01-01 – 2021-12-31: -12697000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2021-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -12697000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12697000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000020/clpt-20221231.htm#1157174 Filing: 000128555023000020 The citation records this snapshot. The page link may show a newer release later.	USD 168,000 Exact value Exact value: 168000 USD 2021-01-01 – 2021-12-31: 168000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2021-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 168000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 168000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000020/clpt-20221231.htm#1159756 Filing: 000128555023000020 The citation records this snapshot. The page link may show a newer release later.	−USD 12.87 million Calculation and evidence -12697000 − 168000 USD Exact free cash flow: -12865000 USD 2021-01-01 – 2021-12-31: -12697000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 168000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2021-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -12865000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12697000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000020/clpt-20221231.htm#1157174 Filing: 000128555023000020 Input fundies:CapitalExpenditure: 168000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000020/clpt-20221231.htm#1159756 Filing: 000128555023000020 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 16.44 million Exact value Exact value: -16435000 USD 2022-01-01 – 2022-12-31: -16435000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2022-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -16435000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16435000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000031/clpt-20231231.htm#1017495 Filing: 000128555024000031 The citation records this snapshot. The page link may show a newer release later.	−USD 16.17 million Exact value Exact value: -16167000 USD 2022-01-01 – 2022-12-31: -16167000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2022-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -16167000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16167000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000031/clpt-20231231.htm#1036864 Filing: 000128555024000031 The citation records this snapshot. The page link may show a newer release later.	USD 253,000 Exact value Exact value: 253000 USD 2022-01-01 – 2022-12-31: 253000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2022-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 253000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 253000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000031/clpt-20231231.htm#1038653 Filing: 000128555024000031 The citation records this snapshot. The page link may show a newer release later.	−USD 16.42 million Calculation and evidence -16167000 − 253000 USD Exact free cash flow: -16420000 USD 2022-01-01 – 2022-12-31: -16167000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 253000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2022-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -16420000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16167000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000031/clpt-20231231.htm#1036864 Filing: 000128555024000031 Input fundies:CapitalExpenditure: 253000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000031/clpt-20231231.htm#1038653 Filing: 000128555024000031 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 22.09 million Exact value Exact value: -22089000 USD 2023-01-01 – 2023-12-31: -22089000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2023-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -22089000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22089000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000095017025027934/clpt-20241231.htm#1792754 Filing: 000095017025027934 The citation records this snapshot. The page link may show a newer release later.	−USD 13.72 million Exact value Exact value: -13720000 USD 2023-01-01 – 2023-12-31: -13720000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2023-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -13720000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13720000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000095017025027934/clpt-20241231.htm#1848447 Filing: 000095017025027934 The citation records this snapshot. The page link may show a newer release later.	USD 717,000 Exact value Exact value: 717000 USD 2023-01-01 – 2023-12-31: 717000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2023-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 717000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 717000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000095017025027934/clpt-20241231.htm#1854549 Filing: 000095017025027934 The citation records this snapshot. The page link may show a newer release later.	−USD 14.44 million Calculation and evidence -13720000 − 717000 USD Exact free cash flow: -14437000 USD 2023-01-01 – 2023-12-31: -13720000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 717000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2023-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -14437000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13720000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000095017025027934/clpt-20241231.htm#1848447 Filing: 000095017025027934 Input fundies:CapitalExpenditure: 717000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000095017025027934/clpt-20241231.htm#1854549 Filing: 000095017025027934 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 18.91 million Exact value Exact value: -18914000 USD 2024-01-01 – 2024-12-31: -18914000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2024-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -18914000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18914000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2120023 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.	−USD 8.95 million Exact value Exact value: -8950000 USD 2024-01-01 – 2024-12-31: -8950000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2024-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -8950000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8950000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2183868 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.	USD 275,000 Exact value Exact value: 275000 USD 2024-01-01 – 2024-12-31: 275000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2024-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 275000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 275000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2194413 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.	−USD 9.23 million Calculation and evidence -8950000 − 275000 USD Exact free cash flow: -9225000 USD 2024-01-01 – 2024-12-31: -8950000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 275000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2024-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -9225000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8950000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2183868 Filing: 000119312526111231 Input fundies:CapitalExpenditure: 275000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2194413 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 25.54 million Exact value Exact value: -25540000 USD 2025-01-01 – 2025-12-31: -25540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Net Income: -25540000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25540000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2118292 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.	−USD 23.9 million Exact value Exact value: -23900000 USD 2025-01-01 – 2025-12-31: -23900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Operating Cash Flow: -23900000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526436412/clpt-20260930.htm#1147028 Filing: 000119312526436412 The citation records this snapshot. The page link may show a newer release later.	USD 522,000 Exact value Exact value: 522000 USD 2025-01-01 – 2025-12-31: 522000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Capital Expenditure: 522000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 522000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2192536 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.	−USD 24.42 million Calculation and evidence -23900000 − 522000 USD Exact free cash flow: -24422000 USD 2025-01-01 – 2025-12-31: -23900000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 522000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CLEARPOINT NEURO, INC. · 2025-12-31 CLEARPOINT NEURO, INC. (edgar:1285550) Free cash flow: -24422000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T20:09:58Z Snapshot: f0ca953f558710cf86e44f6d04406d6abb76a3df6e96032fa91ad1d01e692a26 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1285550?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526436412/clpt-20260930.htm#1147028 Filing: 000119312526436412 Input fundies:CapitalExpenditure: 522000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm#2192536 Filing: 000119312526111231 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

131 filings · 4,316 latest values · 4,316 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001285550, 1285550, CLPT, MRIC, MRICD, edgar:1285550, mric

Also known as CLEARPOINT NEURO, INC., ClearPoint Neuro, Inc., MRI INTERVENTIONS, INC., SURGI VISION INC, SURGIVISION INC

CLEARPOINT NEURO, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation